References
- JohanssonRCarlbringPHeedmanÅPaxlingBAnderssonGDepression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of lifePeer J20131e9823862109
- KesslerRCBirnbaumHGShahlyVAge differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey InitiativeDepress Anxiety201027435136420037917
- RapaportMHPrevalence, recognition and treatment of comorbid depression and anxietyJ Clin Psychiatry200162Suppl 2461011676431
- TillerJWGDepression and anxietyMed J Aust Open20121 Suppl 42832
- FavaMRushAJAlpertJEDifference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D reportAm J Psychiatry2008165334235118172020
- NelsonJCAnxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trialsDepress Anxiety2010271121820013987
- NelsonJCDelucchiKSchneiderLSAnxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysisInt J Geriatr Psychiatry200924553954419334041
- RussellJMKoranLMRushJEffect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depressionDepress Anxiety2004131182711233456
- AltamuraACMontresorCSalvadoriDMundoEDoes comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic studyInt J Neuropsychopharmacol20047448148715469668
- ClaytonPJGroveWMCoryellWFollow-up and family study of anxious depressionAm J Psychiatry199114811151215171928465
- GaynesBNMagruderKMBurnsBJDoes a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression?Gen Hosp Psychiatry199921315816710378109
- ThaseMEDemyttenaereKEarleyWRExtended release quetiapine fumarate in major depressive disorder: analysis in patients with anxious depressionDepress Anxiety201229757458622753280
- UherRDernovsekMZMorsOMelancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptylineJ Affect Disord20111321–211212021411156
- SeoHJSongHRJeongSDoes comorbid subthreshold anxiety predict treatment response in depression? Results from a naturalistic cohort study (the CRESCEND study)J Affect Disord2014152–154352359
- Means-ChristensenAJRoy-ByrnePPSherbourneCDCraskeMGSteinMBRelationships among pain, anxiety, and depression in primary careDepress Anxiety200825759360017932958
- GurejeOSimonGEVon KorffMA cross-national study of the course of persistent pain in primary carePain2001921–219520011323140
- MerglRSeidscheckIAllgaierAKDepressive, anxiety, and somatoform disorders in primary care: prevalence and recognitionDepress Anxiety200724318519516900465
- CastilloRCWegenerSTHeinsSEfor the LEAP Study Group. Longitudinal relationships between anxiety, depression, and pain: results from a two-year cohort study of lower extremity trauma patientsPain2013154122860286623994104
- NovickDMontgomeryWAguadoJWhich somatic symptoms are associated with an unfavorable course in Asian patients with major depressive disorder?J Affect Disord20131491–318218823521872
- NovickDMontgomeryWKadziolaZDo concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?Patient Prefer Adherence2013746347023818764
- LiYShiSYangFPatterns of co-morbidity with anxiety disorders in Chinese women with recurrent major depressionPsychol Med20124261239124822126712
- LeePZhangMHongJPFrequency of painful physical symptoms with major depressive disorder in Asia: relationship with disease severity and quality of lifeJ Clin Psychiatry2009701839119192462
- American Psychiatric Association (APA)Diagnostic and Statistical Manual of Mental Disorders Text Revision: DSM-IV-TRWashington, DCAmerican Psychiatric Press2000
- World Health Organization (WHO)International Classification of Diseases and Related World Health ProblemsGeneva, SwitzerlandWHO2007
- GuyWECDEU Assessment Manual for Psychopharmacology, RevisedBethesda, MDUS Department of Health, Education, and Welfare1976
- HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
- KroenkeKSpitzerRLWilliamsJBPhysical symptoms in primary care. Predictors of psychiatric disorders and functional impairmentArch Fam Med1994397747797987511
- BrooksRRabinRde CharroFThe Measurement and Valuation of Health Status Using EQ-5D: A European PerspectiveDordrecht, The NetherlandsKluwer Academic Publishers2003
- KindPHardmanGMacranSUK population norms for EQ-5DWorking Paper #172York, UKYork Centre for Health Economics1999
- LamTPGoldbergDPDowellACProposed new diagnoses of anxious depression and bodily stress syndrome in ICD-11-PHC: an international focus group studyFam Pract2013301768722843638
- HamiltonMThe assessment of anxiety states by ratingBr J Med Psychol195932505513638508
- CiprianiAFurukawaTASalantiGComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysisLancet2009373966574675819185342
- BasbaumAIFieldsHLEndogenous pain control mechanisms: review and hypothesisAnn Neurol197845451462216303
- RexAFinkHNeurotransmitter and behaviour: serotonin and anxietyUeharaTPsychiatric Disorders – Trends and Developments2001InTech Available from: http://www.intechopen.com/books/psychiatric-disorders-trends-and-developments/neurotransmitter-and-behaviour-serotonin-and-anxietyAccessed July 28, 2014
- KapfhammerH-PSomatic symptoms in depressionDialogues Clin Neurosci20068222723916889108
- GriebelG5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of researchPharmacol Ther19956533193957644567
- JohnsonJALuoNShawJWKindPCoonsSJValuations of EQ-5D health states: are the United States and United Kingdom different?Med Care200543322122815725978
- FuAZKattanMWRacial and ethnic differences in preference-based health status measureCurr Med Res Opin200622122439244817257458
- NormanRCroninPVineyRInternational comparisons in valuing EQ-5D health states: a review and analysisValue Health20091281194120019695009
- SapinCFantinoBNowickiMLKindPUsefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderHealth Qual Life Outcomes200422015128456
- WangHMPatrickDLEdwardsTCValidation of the EQ-5D in a general population sample in urban ChinaQual Life Res201221115516021505881
- GerhardsSAHuibersMJTheunissenKAThe responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD)Value Health201114573273921839412